Alkermes' alixorexton has become the first drug in the orexin 2 receptor agonist class to show efficacy in phase 2 trials involving patients with both main subtypes of sleep disorder narcolepsy.
OpenDRIVE <=> CR crdesigner/map_conversion/opendrive Conversion from OpenDRIVE to CommonRoad and vice versa. Lanelet/Lanelet2 <=> CR crdesigner/map_conversion/lanelet2 Conversion from Lanelet2 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results